---
title: "Insilico Medicine Grants 108,423 Restricted Share Units to Employees"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303564069.md"
description: "Insilico Medicine granted 108,423 restricted share units (RSUs) to three employees on October 29, 2026, under its Post-IPO RSU Scheme. The awards include special vesting schedules: two employees receive 69,540 RSUs vesting quarterly in eighths starting October 30, 2026, while one employee receives 38,883 RSUs with specific anniversary-based vesting. Recipients must meet annual performance criteria."
datetime: "2026-10-29T12:12:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303564069.md)
  - [en](https://longbridge.com/en/news/303564069.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303564069.md)
generator: "portal-rs"
---

# Insilico Medicine Grants 108,423 Restricted Share Units to Employees

-   Insilico Medicine granted 108,423 restricted share units to three employees on October 29, 2026, under its Post-IPO RSU Scheme. \* Special awards totaling 69,540 RSUs for two employees vest in eighths quarterly starting October 30, 2026. \* One employee’s 38,883 RSUs vest two-thirds on their second employment anniversary, no earlier than 12 months post-grant, then one-twelfth quarterly thereafter. \* Vesting requires recipients to meet or exceed applicable annual performance review criteria. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261029-12388271), on October 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [03696.HK](https://longbridge.com/en/quote/03696.HK.md)
- [00388.HK](https://longbridge.com/en/quote/00388.HK.md)

## Related News & Research

- [Insilico Medicine Subsidiary Partners With Luoxin Pharmaceuticals on AI-Powered Drug Discovery](https://longbridge.com/en/news/305433887.md)
- [INSILICO Plans Share Buyback of Up to HKD500M](https://longbridge.com/en/news/303654455.md)
- [Chainfir Capital says AI drug deal headlines mask reliance on uncertain milestone payments](https://longbridge.com/en/news/302495363.md)
- [Insilico Medicine Reports 40% Response Rate at 130 mg for ISM6331 in Phase 1 Mesothelioma Trial](https://longbridge.com/en/news/303086760.md)
- [InSilico Medicine Hits Early AI Drug Discovery Milestone in Servier Collaboration](https://longbridge.com/en/news/302341377.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**